Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer

feature-image

Play all audios:

Loading...

ABSTRACT Herpes simplex virus-1 (HSV-1) oncolytic therapy and gene therapy are promising treatment modalities against cancer. NV1066, one such HSV-1 virus, carries a marker gene for enhanced


green fluorescent protein (EGFP). The purpose of this study was to determine whether NV1066 is cytotoxic to lung cancer and whether EGFP is a detectable marker of viral infection _in vitro_


and _in vivo_. We further investigated whether EGFP expression in infected cells can be used to localize the virus and to identify small metastatic tumor foci (<1 mm) _in vivo_ by means


of minimally invasive endoscopic systems equipped with fluorescent filters. In A549 human lung cancer cells, _in vitro_ viral replication was determined by plaque assay, cell kill by LDH


release assay, and EGFP expression by flow cytometry. _In vivo_, A549 cells were injected into the pleural cavity of athymic mice. Mice were treated with intrapleural injection of NV1066 or


saline and examined for EGFP expression in tumor deposits using a stereomicroscope or a fluorescent thoracoscopic system. NV1066 replicated in, expressed EGFP in infected cells and killed


tumor cells _in vitro_. _In vivo_, treatment with intrapleural NV1066 decreased pleural disease burden, as measured by chest wall nodule counts and organ weights. EGFP was easily visualized


in tumor deposits, including microscopic foci, by fluorescent thoracoscopy. NV1066 has significant oncolytic activity against a human NSCLC cell line and is effective in limiting the


progression of metastatic disease in an _in vivo_ orthotopic model. By incorporating fluorescent filters into endoscopic systems, a minimally invasive means for diagnosing small metastatic


pleural deposits and localization of viral therapy for thoracic malignancies may be developed using the EGFP marker gene inserted in oncolytic herpes simplex viruses. Access through your


institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print


issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to


local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT


BEING VIEWED BY OTHERS VIRUS NANOTECHNOLOGY FOR INTRATUMOURAL IMMUNOTHERAPY Article 23 September 2024 INTRAPERITONEAL ADMINISTRATION OF ADENO-ASSOCIATED VIRUS ENCODING MICRORNA-29B FOR THE


TREATMENT OF PERITONEAL METASTASIS Article 10 October 2024 INHIBITION OF ORTHOTOPIC CASTRATION-RESISTANT PROSTATE CANCER GROWTH AND METASTASIS IN MICE BY JC VLPS CARRYING A SUICIDE GENE


DRIVEN BY THE PSA PROMOTER Article Open access 11 December 2023 ABBREVIATIONS * CMV: cytomegalovirus * EGFP: enhanced green fluorescent protein * HSV-1: herpes simplex virus-1 * LDH: lactate


dehydrogenase * MIS: minimally invasive surgical REFERENCES * 2004 Cancer Facts & Figures Available at: http://www.cancer.org/downloads/STT?CAFF_finalPWSecured.pdf (accessed July 1,


2004). * Carney DN . Lung cancer – time to move on from chemotherapy. _N Engl J Med_ 2002; 346 (2): 126–128. Article  Google Scholar  * Roizman B . The function of herpes simplex virus


genes: a primer for genetic engineering of novel vectors. _Proc Natl Acad Sci USA_ 1996; 93 (21): 11307–11312. Article  CAS  Google Scholar  * Mineta T, Rabkin SD, Yazaki T, Hunter WD,


Martuza RL . Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. _Nat Med_ 1995; 1 (9): 938–943. Article  CAS  Google Scholar  * Fong Y, Kemeny N,


Jarnagin S, Stanziale S, Guilfoyle B, Gusani N et al. Phase 1 study of a replication-competent Herpes Simplex oncolytic virus for treatment of hepatic colorectal metastases. Abstract # 27.


_American Society of Clinical Oncology 38th Annual Meeting Proceedings_, vol. 2: Part 1, 8a, 2002. * Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D et al.


Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. _Gene Therapy_ 2000; 7 (10): 859–866. Article  CAS


  Google Scholar  * Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y . Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by


a cytotoxic herpes simplex virus type 1 (G207). _Hum Gene Ther_ 1999; 10 (10): 1599–1606. Article  CAS  Google Scholar  * Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD


et al. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. _Gene Therapy_ 2000; 7 (10): 867–874. Article  CAS 


Google Scholar  * Stiles BM, Bhargava A, Adusumilli PS, Stanziale SF, Kim TH, Rusch VW et al. The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the


treatment of esophageal cancer. _Surgery_ 2003; 134 (2): 357–364. Article  Google Scholar  * Bennett JJ, Adusumilli P, Petrowsky H, Burt BM, Roberts G, Delman KA et al. Up-regulation of


GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207). _FASEB J_ 2004; 18 (9): 1001–1003. Article  CAS  Google Scholar  *


Jiao X, Krasna MJ . Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. _Ann Thorac Surg_ 2002; 74 (1): 278–284. Article  Google


Scholar  * Dresler CM, Fratelli C, Babb J . Prognostic value of positive pleural lavage in patients with lung cancer resection. _Ann Thorac Surg_ 1999; 67 (5): 1435–1439. Article  CAS 


Google Scholar  * Okumura M, Ohshima S, Kotake Y, Morino H, Kikui M, Yasumitsu T . Intraoperative pleural lavage cytology in lung cancer patients. _Ann Thorac Surg_ 1991; 51 (4): 599–604.


Article  CAS  Google Scholar  * Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R, Horai T et al. Pleural lavage cytology immediately after thoracotomy and before closure of the


thoracic cavity for lung cancer without pleural effusion and dissemination: clinicopathologic and prognostic analysis. _Ann Surg Oncol_ 1997; 4 (5): 409–415. Article  CAS  Google Scholar  *


Buhr J, Berghauser KH, Gonner S, Kelm C, Burkhardt EA, Padberg WM . The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients


with lung cancer. _J Thorac Cardiovasc Surg_ 1997; 113 (4): 683–690. Article  CAS  Google Scholar  * Kondo H, Asamura H, Suemasu K, Goya T, Tsuchiya R, Naruke T et al. Prognostic


significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer. _J Thorac Cardiovasc Surg_ 1993; 106 (6): 1092–1097. CAS  PubMed  Google Scholar  * Wong


RJ, Joe JK, Kim SH, Shah JP, Horsburgh B, Fong Y . Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic


metastases. _Hum Gene Ther_ 2002; 13 (10): 1213–1223. Article  CAS  Google Scholar  * Stanziale SF, Stiles BM, Bhargava A, Kerns SA, Kalakonda N, Fong Y . Oncolytic herpes simplex virus-1


mutant expressing green fluorescent protein can detect and treat peritoneal cancer. _Hum Gene Ther_ 2004; 15 (6): 609–618. Article  CAS  Google Scholar  * Cormack BP, Valdivia RH, Falkow S .


FACS-optimized mutants of the green fluorescent protein (GFP). _Gene_ 1996; 173 (Spec. No.): 33–38. Article  CAS  Google Scholar  * Nunez R, Ackermann M, Saeki Y, Chiocca A, Fraefel C .


Flow cytometric assessment of transduction efficiency and cytotoxicity of herpes simplex virus type 1-based amplicon vectors. _Cytometry_ 2001; 44 (2): 93–99. Article  CAS  Google Scholar  *


O'shea CC . DNA tumor viruses – the spies who lyse us. _Curr Opin Genet Dev_ 2005; 15 (1): 18–26. Article  CAS  Google Scholar  * Toda M, Rabkin SD, Martuza RL . Treatment of human


breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. _Hum Gene Ther_ 1998; 9 (15): 2177–2185. Article  CAS  Google Scholar  *


Nakamura H, Kasuya H, Mullen JT, Yoon SS, Pawlik TM, Chandrasekhar S et al. Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.


_J Clin Invest_ 2002; 109 (7): 871–882. Article  CAS  Google Scholar  * Ebright MI, Zager JS, Malhotra S, Delman KA, Weigel TL, Rusch VW et al. Replication-competent herpes virus NV1020 as


direct treatment of pleural cancer in a rat model. _J Thorac Cardiovasc Surg_ 2002; 124 (1): 123–129. Article  Google Scholar  * Kooby DA, Carew JF, Halterman MW, Mack JE, Bertino JR,


Blumgart LH et al. Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). _FASEB J_ 1999; 13 (11): 1325–1334.


Article  CAS  Google Scholar  * Varghese S, Rabkin SD . Oncolytic herpes simplex virus vectors for cancer virotherapy. _Cancer Gene Ther_ 2002; 9 (12): 967–978. Article  CAS  Google Scholar


  * Kjellberg SI, Dresler CM, Goldberg M . Pleural cytologies in lung cancer without pleural effusions. _Ann Thorac Surg_ 1997; 64 (4): 941–944. Article  CAS  Google Scholar  * Okada M,


Tsubota N, Yoshimura M, Miyamoto Y, Maniwa Y . Role of pleural lavage cytology before resection for primary lung carcinoma. _Ann Surg_ 1999; 229 (4): 579–584. Article  CAS  Google Scholar  *


Sahn SA, Good Jr JT . Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. _Ann Intern Med_ 1988; 108 (3): 345–349. Article  CAS  Google Scholar  *


Johnston WW . The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. _Cancer_ 1985; 56 (4): 905–909. Article  CAS  Google


Scholar  * DiBonito L, Falconieri G, Colautti I, Bonifacio D, Dudine S . The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. _Acta


Cytol_ 1992; 36 (3): 329–332. CAS  PubMed  Google Scholar  * Chernow B, Sahn SA . Carcinomatous involvement of the pleura: an analysis of 96 patients. _Am J Med_ 1977; 63 (5): 695–702.


Article  CAS  Google Scholar  * Ichinose Y, Tsuchiya R, Koike T, Yasumitsu T, Nakamura K, Tada H et al. A prematurely terminated phase III trial of intraoperative intrapleural hypotonic


cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: the incidence of carcinomatous pleuritis after surgical intervention. _J


Thorac Cardiovasc Surg_ 2002; 123 (4): 695–699. Article  Google Scholar  * Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B et al. Positron emission tomography-based


imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors _in vivo_. _Cancer Res_ 2001; 61 (7): 2983–2995. CAS  Google Scholar


  * Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE et al. _In vivo_ molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. _J Natl Cancer


Inst_ 2002; 94 (10): 741–749. Article  CAS  Google Scholar  * Lerondel S, Le Pape A, Sene C, Faure L, Bernard S, Diot P et al. Radioisotopic imaging allows optimization of adenovirus lung


deposition for cystic fibrosis gene therapy. _Hum Gene Ther_ 2001; 12: 1–11. Article  CAS  Google Scholar  * Bennett JJ, Tjuvajev J, Johnson P, Doubrovin M, Akhurst T, Malholtra S et al.


Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer. _Nat Med_ 2001; 7: 859–863. Article  CAS  Google Scholar  *


Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G . Adenovirus biodistribution and noninvasive imaging of gene expression _in vivo_ by positron emission tomography using human


sodium/iodide symporter as reporter gene. _Hum Gene Ther_ 2002; 13 (14): 1723–1735. Article  CAS  Google Scholar  * Haberkorn U, Altmann A . Functional genomics and radioisotope-based


imaging procedures. _Ann Med_ 2003; 35 (6): 370–379. Article  CAS  Google Scholar  * Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L et al. Whole-body optical imaging of green fluorescent


protein-expressing tumors and metastases. _Proc Natl Acad Sci USA_ 2000; 97 (3): 1206–1211. Article  CAS  Google Scholar  * Yang M, Baranov E, Moossa AR, Penman S, Hoffman RM . Visualizing


gene expression by whole-body fluorescence imaging. _Proc Natl Acad Sci USA_ 2000; 97 (22): 12278–12282. Article  CAS  Google Scholar  * Jacobs A, Dubrovin M, Hewett J, Sena-Esteves M, Tan


CW, Slack M et al. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. _Neoplasia_ 1999; 1 (2):


154–161. Article  CAS  Google Scholar  * Paquin A, Jaalouk DE, Galipeau J . Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a


versatile suicide/reporter for cell and gene therapy applications. _Hum Gene Ther_ 2001; 12 (1): 13–23. Article  CAS  Google Scholar  * Mazurier F, Moreau-Gaudry F, Maguer-Satta V, Salesse


S, Pigeonnier-Lagarde V, Ged C et al. Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using the humanized S65T green fluorescent protein. _Gene


Therapy_ 1998; 5 (4): 556–562. Article  CAS  Google Scholar  * Tsutsudaasano A, Migita M, Takahashi K, Shimada T . Transduction of fibroblasts and CD34+ progenitors using a selectable


retroviral vector containing cDNAs encoding arylsulfatase A and CD24. _J Hum Genet_ 2000; 45 (1): 18–23. Article  CAS  Google Scholar  * Hunt L, Jordan M, De Jesus M, Wurm FM .


GFP-expressing mammalian cells for fast, sensitive, noninvasive cell growth assessment in a kinetic mode. _Biotechnol Bioeng_ 1999; 65 (2): 201–205. Article  CAS  Google Scholar  * Prosst


RL, Winkler S, Boehm E, Gahlen J . Thoracoscopic fluorescence diagnosis (TFD) of pleural malignancies: experimental studies. _Thorax_ 2002; 57 (12): 1005–1009. Article  CAS  Google Scholar 


* Gahlen J, Stern J, Laubach HH, Pietschmann M, Herfarth C . Improving diagnostic staging laparoscopy using intraperitoneal lavage of delta-aminolevulinic acid (ALA) for laparoscopic


fluorescence diagnosis. _Surgery_ 1999; 126 (3): 469–473. Article  CAS  Google Scholar  * Gahlen J, Prosst RL, Pietschmann M, Rheinwald M, Haase T, Herfarth C . Spectrometry supports


fluorescence staging laparoscopy after intraperitoneal aminolaevulinic acid lavage for gastrointestinal tumours. _J Photochem Photobiol B_ 1999; 52 (1–3): 131–135. Article  CAS  Google


Scholar  * Gahlen J, Prosst RL, Pietschmann M, Haase T, Rheinwald M, Skopp G et al. Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis


experimental studies. _Ann Surg_ 2002; 235 (2): 252–260. Article  Google Scholar  * Chishima T, Miyagi Y, Wang X, Yamaoka H, Shimada H, Moossa AR et al. Cancer invasion and micrometastasis


visualized in live tissue by green fluorescent protein expression. _Cancer Res_ 1997; 57 (10): 2042–2047. CAS  Google Scholar  * Chishima T, Miyagi Y, Wang X, Baranov E, Tan Y, Shimada H et


al. Metastatic patterns of lung cancer visualized live and in process by green fluorescence protein expression. _Clin Exp Metastasis_ 1997; 15 (5): 547–552. Article  CAS  Google Scholar  *


Chishima T, Miyagi Y, Wang X, Tan Y, Shimada H, Moossa A et al. Visualization of the metastatic process by green fluorescent protein expression. _Anticancer Res_ 1997; 17 (4A): 2377–2384.


CAS  PubMed  Google Scholar  * Hasegawa S, Yang M, Chishima T, Miyagi Y, Shimada H, Moossa AR et al. _In vivo_ tumor delivery of the green fluorescent protein gene to report future


occurrence of metastasis. _Cancer Gene Ther_ 2000; 7 (10): 1336–1340. Article  CAS  Google Scholar  * Diehn FE, Costouros NG, Miller MS, Feldman AL, Alexander HR, Li KC et al. Noninvasive


fluorescent imaging reliably estimates biomass _in vivo_. _Biotechniques_ 2002; 33 (6): 1250–1255. Article  CAS  Google Scholar  * Robinson PJ . Imaging liver metastases: current limitations


and future prospects. _Br J Radiol_ 2000; 73 (867): 234–241. Article  CAS  Google Scholar  * Hirsch FR, Franklin WA, Gazdar AF, Bunn Jr PA . Early detection of lung cancer: clinical


perspectives of recent advances in biology and radiology. _Clin Cancer Res_ 2001; 7 (1): 5–22. CAS  PubMed  Google Scholar  Download references ACKNOWLEDGEMENTS We thank Brian Horsburgh, PhD


and Medigene, Inc. for constructing and providing us with the NV1066 virus. We thank Mithat Gonen, PhD, of the Department of Epidemiology and Biostatistics, and Katia Manova, PhD, John


Waka, BS, and members of the Molecular Cytology Core Facility at Memorial Sloan-Kettering Cancer Center for their assistance with this project. We thank Hai Nguyen, VMD, of the Research


Animal Resource Center of Cornell University Medical College for review of pathology specimens. Special thanks to Kan Matsumoto from Olympus America Inc., for design and construction of the


fluorescent thoracoscopic system. This study was presented at the sixth annual meeting of the ‘American Society of Gene Therapy’, 2003, in Washington DC. This work was supported in part by


training grant T32 CA09501 (BMS), AACR-AstraZeneca Cancer Research and Prevention Foundation Fellowship (PSA), grants RO1 CA 76416 and RO1 CA/DK80982 (YF) from the National Institutes of


Health, grant MBC-99366 (YF) from the American Cancer Society, grant BC024118 from the US Army (YF), grant IMG0402501 from the Susan Komen Cancer foundation (YF and PSA) and grant 032047


from Flight Attendant Medical Research Institute (YF and PSA). AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA


B M Stiles, P S Adusumilli, A Bhargava, S F Stanziale, T H Kim, M-K Chan, R Wong, V W Rusch & Y Fong * Molecular Cytology Core Facility, Memorial Sloan-Kettering Cancer Center, New York,


NY, USA R Huq Authors * B M Stiles View author publications You can also search for this author inPubMed Google Scholar * P S Adusumilli View author publications You can also search for


this author inPubMed Google Scholar * A Bhargava View author publications You can also search for this author inPubMed Google Scholar * S F Stanziale View author publications You can also


search for this author inPubMed Google Scholar * T H Kim View author publications You can also search for this author inPubMed Google Scholar * M-K Chan View author publications You can also


search for this author inPubMed Google Scholar * R Huq View author publications You can also search for this author inPubMed Google Scholar * R Wong View author publications You can also


search for this author inPubMed Google Scholar * V W Rusch View author publications You can also search for this author inPubMed Google Scholar * Y Fong View author publications You can also


search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Y Fong. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Stiles,


B., Adusumilli, P., Bhargava, A. _et al._ Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. _Cancer Gene Ther_ 13, 53–64 (2006).


https://doi.org/10.1038/sj.cgt.7700860 Download citation * Received: 09 November 2004 * Revised: 16 March 2005 * Accepted: 17 March 2005 * Published: 22 July 2005 * Issue Date: 01 January


2006 * DOI: https://doi.org/10.1038/sj.cgt.7700860 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link


is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * green fluorescent protein * lung neoplasm *


minimally invasive * targeted therapy * thoracoscopy * bronchoscopy